Notice of Annual General Meeting 2024 in Enzymatica AB (publ)
/PRNewswire/ -- The annual general meeting of Enzymatica AB (publ), reg. no. 556719-9244, will be held on 7 May 2024 at 14:30 CET, Elite Hotel Ideon,...
Source: prnewswire.com
📰 Enzymatica Ab News
Enzymatica Ab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Enzymatica Ab. Real-time updates on events, politics, business and more.
Enzymatica publishes information memorandum about rights issue of shares
/PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has published an information memorandum regarding the rights...
Source: prnewswire.com
Enzymatica's rights issue is secured to 100 percent
/PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or "the Company") decided on February 16, 2024, to carry out a rights issue of SEK...
South Korea South Africa Stefan Olsson Claus Egstrand Setterwalls Advokatbyr Hagberg Aneborn Fondkommission
Source: prnewswire.com
Enzymatica's Board of Directors decides on a new rights issue of SEK 27.4 million
/PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 27.4...
Source: prnewswire.co.uk
Year-end report 2023: Scientific and regulatory progress generating international interest
/PRNewswire/ -- Fourth quarter January-December • Net sales reached SEK 15.8 (16.6) million. • The operating result totaled SEK -13.8 (-21.6) million. •...
Claus Egstrand Stefan Olsson Glen Davison University Of Kent Certified Adviser To Carnegie Investment Bank Enzymatica Certified Adviser Is Carnegie Investment Bank
Source: prnewswire.com
Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat
/PRNewswire/ -- The first results from an ongoing independent clinical study at the University of Kent, UK, show that ColdZyme® significantly reduces the viral...
Source: prnewswire.com
Interim report Q1/2023: Strong start to the year - Enzymatica's growth journey continues according to plan
/PRNewswire/ -- First quarter Net sales reached SEK 13.0 (4.2) million. The operating result totaled SEK -14.4 (-18.1) million. Earnings per share, basic and...
Claus Egstrand Stefan Olsson Enzymatica Certified Adviser Is Erik Penser Bank Executive Officer Nasdaq First North Growth Certified Adviser
Source: prnewswire.com
Enzymatica AB: Interim report Q4/2022: A year that laid the foundation for growth
/PRNewswire/ -- Significant events during the quarter Significant events after the quarter On October 31, the journal Respiratory Research published an...
Claus Egstrand Stefan Olsson University Of Kent United Kingdom Enzymatica Certified Adviser Is Erik Penser Bank Respiratory Research Medical University
Source: prnewswire.com
Enzymatica AB Interim report Q3/2022: A broader role for ColdZyme adds potential for the future
/PRNewswire/ -- Significant events during the quarter Significant events after the quarter · To ensure the long-term financing of the business, in September...
Source: prnewswire.com
Enzymatica publishes supplementary prospectus
/PRNewswire/ -- The Board of Directors of Enzymatica AB ("Enzymatica" or "Company") has issued a supplement (the "Supplementary Prospectus") in addition to the...
Source: prnewswire.co.uk